BioWorld MedTech

June 16, 2014

TAVR/TAVI Takes Center Stage: Shift toward lower-risk patient pools seen as key growth driver for TAVR

The topic of the transcatheter valve replacement (TAVR) market, also known as transcatheter valve implantation (TAVI), brings to mind the classic Dr. Seuss story, "Oh, the Places You'll Go." Read More

Breakout Labs gives leg up to device firms seeking funding

FDA Advisory Committee: Lutonix comes away with win at advisory for drug-coated balloon

MDD's Stock Watch

Agreements/contracts: PerkinElmer to distribute Sofie PET technology

World in Review: Biotronik publishes the results from PEACE 1 all-comers registry

Financings: Envision prices 2022 note offering at $750 million, up from $650 million

Briefly Noted

Product briefs

People in Places

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...